Clonal Evolution

Hopeful Monster

Properties1
tagsfoundations, genomic-alterations

10 min read

Hopeful Monster

Definition

A hopeful monster is an individual carrying a mutation of large phenotypic effect that, while usually deleterious or lethal, may occasionally be adaptive in the right environment — founding a new lineage through discontinuous evolutionary change rather than gradual, stepwise accumulation of small-effect mutations (Goldschmidt, 1933, 1940). In cancer, the term was adopted by Turajlic et al. (2019) to describe clones with grossly altered genomes — products of chromothripsis, whole-genome duplication, or explosive chromosomal instability — that may be adaptive and expand to dominate the tumor population.

Historical Controversy

Richard Goldschmidt introduced the concept in the 1930s to address a puzzle: how do radical changes in morphology evolve? His key example was flatfish (flounder and relatives), which descend from bilaterally symmetrical ancestors but develop profound asymmetry as adults — one eye migrates across the skull, the skull deforms, one side flattens. Goldschmidt speculated that such transformations could arise through single mutations acting on embryonic development, rather than through thousands of generations of incremental change (Judson, 2008).

The idea was immediately controversial. Ronald Fisher — the architect of population-genetic orthodoxy — argued by analogy: focusing a microscope, small adjustments are more likely to produce improvement than large ones. Mutations of large effect are overwhelmingly likely to be deleterious; the probability that a macromutation is simultaneously viable AND beneficial is vanishingly small. This reasoning became the theoretical consensus: adaptation proceeds through the accumulation of mutations of small effect, and hopeful monsters are a “freak show” irrelevant to evolutionary process (Judson, 2008; orr2005-genetic-theory-of-adaptation).

For decades, the consensus held. Mutations of large morphological effect were known (naked-neck chickens, situs inversus in humans, white blackbirds) but considered evolutionary dead ends.

Modern Revival in Developmental Genetics

Beginning in the early 2000s, molecular developmental genetics provided evidence that single-gene mutations can produce large, potentially adaptive morphological changes (Judson, 2008):

  • Ultrabithorax and the insect body plan. A mutation in the Hox gene Ultrabithorax gives insects six legs while crustaceans — lacking the leg-repression function — have many more. Man-made chimeric gene products (part-insect, part-crustacean) confirmed that the insect version acquired a specific leg-repression domain (Ronshaugen et al., 2002; Galant & Carroll, 2002, cited in Judson, 2008).
  • Sex combs reduced and leg bristles. In Drosophila species, the presence or absence of male leg bristles — a sexually selected trait — is controlled entirely by expression-level differences in a single Hox gene (Barmina & Kopp, 2007, cited in Judson, 2008).
  • Naked necks. A single mutation blocks feather production from shoulder to beak in chickens, suggesting vulture naked necks could have evolved in a single jump rather than through gradual feather-line recession.

The modern consensus is nuanced: large-effect mutations can be important in evolution, particularly when they act on developmental regulatory genes. The question has shifted from “whether” to “how often” (Judson, 2008).

Hopeful Monsters in Cancer

Turajlic et al. (2019) explicitly adopted Goldschmidt’s concept for somatic evolution. The key insight: what is vanishingly rare in species evolution (a viable, adaptive macromutation) becomes routine in cancer, because the mechanisms that generate large-effect genomic change are constitutively active in chromosomally unstable tumors.

flowchart TD
    CIN["Chromosomal Instability<br/>(ongoing segregation errors)"] --> CT["Chromothripsis<br/>1-2 chromosomes shattered,<br/>error-prone reassembly"]
    CIN --> WGD["Whole-Genome Doubling<br/>tetraploidization →<br/>asymmetric chromosome loss"]
    CIN --> CPX["Chromoplexy<br/>complex multi-chromosome<br/>rearrangements"]

    CT --> HM["Hopeful Monster<br/>grossly altered clone"]
    WGD --> HM
    CPX --> HM

    HM -->|"Usually"| Death["Lethal<br/>non-viable genome"]
    HM -->|"Rarely"| Adaptive["Adaptive<br/>new fitness state"]

    Adaptive --> Sweep["Clonal Expansion<br/>[[clonal-sweep]]"]
    Adaptive --> PE["[[punctuated-evolution]]<br/>rapid genomic change<br/>followed by stasis"]

Chromosomal instability generates hopeful monsters through multiple catastrophic mechanisms. Most grossly altered clones are lethal; the rare adaptive survivor expands, producing the punctuated evolutionary pattern characteristic of many aggressive cancers. Synthesized from Turajlic et al. (2019), PCAWG Consortium (2020), and Gerstung et al. (2020).

Why cancer makes hopeful monsters routine. Three factors distinguish somatic from organismal evolution:

  1. Mutation rate at chromosomal scale. CIN produces ongoing chromosome segregation errors — gains, losses, translocations — at rates orders of magnitude higher than germline mutation rates. Catastrophic events (chromothripsis, chromoplexy) restructure the genome in a single cell division. The supply of large-effect variants is not limiting.

  2. Population size. A tumor of 1 cm³ contains approximately 10⁹ cells. Even if only 1 in 10⁶ grossly altered clones is viable, that yields ~1,000 hopeful monsters in a modest tumor mass — any one of which could carry an adaptive configuration.

  3. Selective pressure. Therapy, immune surveillance, hypoxia, and nutrient competition create intense selective pressure that can favor radical solutions. A clone that restructures its genome through chromothripsis may simultaneously amplify oncogenes, delete tumor suppressors, and generate fusion drivers — a compound adaptive event that gradual mutation accumulation would require decades to assemble.

PCAWG evidence. The PCAWG Consortium (2020) found chromothripsis in 22.3% of 2,658 pan-cancer samples, predominantly clonal (early event), and enriched for driver events (3.6% of all identified drivers). This is the genomic footprint of hopeful monsters: catastrophic restructuring that occurred early in the tumor’s history, generated a clone with multiple simultaneous driver alterations, and swept through the population.

Hopeful Monsters That Benefit the Organism

The hopeful monster concept has been applied almost exclusively to cancer — grossly altered clones that are adaptive for the tumor but pathogenic for the host. McDermott et al. (2015) provide a striking counterexample: a hopeful monster that benefited both the clone AND the organism. In patient WHIM-09, a chromothriptic event deleted the disease-causing mutant CXCR4 allele in a single HSC, which then repopulated the bone marrow and restored normal immune function — a spontaneous cure of a congenital immunodeficiency (mcdermott2015-chromothriptic-cure-whim).

This case reveals that the hopeful monster concept is broader than its cancer application. The structural logic is identical: a catastrophic genomic event (chromothripsis) produces a rare viable configuration that carries a large fitness advantage → the variant clone expands and dominates the population. The difference is the direction of selection. In cancer, the hopeful monster is selected for proliferation and tissue invasion at the organism’s expense. In WHIM-09, it was selected for normal hematopoietic function, aligning cell-level and organism-level fitness. Somatic evolution is value-neutral — it amplifies whatever variant has the highest relative fitness in the current microenvironment, whether that variant is a KRAS G12D mutation or a chromothriptic deletion that restores normal CXCR4 signaling.

The WHIM-09 case also demonstrates that hopeful monsters are not restricted to chromosomally unstable tissues. The patient’s bone marrow was not cancerous — it had no CIN, no elevated mutation rate, and a small HSC population (~10⁴–10⁵ cells). The three factors that make hopeful monsters “routine” in cancer (high CIN-driven mutation rate, enormous population size, intense selection) were absent. Yet the same logic applied: a single catastrophic event produced a viable, adaptive configuration. This suggests that hopeful monsters may be more common in normal tissues than appreciated — most are lethal and go undetected, but the rare survivor can be transformative.

Cross-Domain Evidence: Hopeful Monsters in Developmental Biology

The hopeful monster concept is not unique to cancer. Hintz et al. (2006) identified a naturally occurring Spe (Stamenoid petals) mutant in shepherd’s purse (Capsella bursa-pastoris) — a homeotic flower variant where petals are replaced by stamens. The Spe phenotype arises from a single co-dominant mutation at one locus (likely ectopic AGAMOUS expression), produces stable wild populations across Europe with no detectable fitness disadvantage, and bypasses the “presumed low fitness of intermediate forms” that is the standard objection to saltational evolution. The structural parallel to cancer hopeful monsters is precise: a single large-effect genetic change produces a radically altered but viable phenotype, without requiring gradual accumulation of small-effect variants. The Spe mutant and chromothriptic WHIM-09 cure occupy the same conceptual category — saltational adaptation — in different biological domains. This cross-domain convergence strengthens the case that hopeful monsters are a general evolutionary phenomenon, not a cancer-specific curiosity. See hintz2006-hopeful-monster-flower.

Relationship to Punctuated Evolution

The hopeful monster is the mechanism; punctuated-evolution is the pattern. A hopeful monster that survives and expands produces the signature of punctuated evolution: rapid, large-scale genomic change followed by relative stasis. The tumor appears to have acquired multiple alterations simultaneously because it did — a single catastrophic event restructured the genome, and the viable products expanded.

This has implications for the detectability of intermediate-clones. If a hopeful monster arises through chromothripsis in a single cell division, there are no intermediate states to sample. The pre-catastrophe clone and the post-catastrophe clone are separated by a single event, not a gradual trajectory. The “missing intermediates” that make punctuated evolution appear discontinuous are not missing — they never existed.

Clinical Significance

“Born to be bad.” Turajlic et al. (2019) report that tumors with early clonal aneuploidy (the product of hopeful-monster events) tend to grow fast, metastasize widely, and seed metastases monophyletically. The hopeful monster acquires metastatic competency at the earliest stages of tumor evolution. The window for early detection may be very limited — “the latency between the emergence of the invasive clone and metastatic spread can be short” (Turajlic et al., 2019, p. 413).

Therapy as hopeful-monster selection. Cytotoxic chemotherapy applies intense selective pressure that can favor hopeful monsters. A clone that survives therapy through a resistance-conferring large-effect mutation (gene amplification, fusion oncogene, catastrophic restructuring that deletes the drug target) is a hopeful monster selected by treatment. The same mechanism that generated the original tumor can generate therapy-resistant relapses.

Exploiting lethal monsters. Most hopeful monsters are lethal — the genomic restructuring produces a non-viable configuration. Therapies that increase the rate of catastrophic genomic events (e.g., by further destabilizing already-unstable genomes) may push tumors past the viability threshold, turning hopeful monsters into lethal ones. This is the rationale for combining DNA-damaging agents with CIN-inducing therapies: overwhelming the tumor’s capacity to produce viable genomic configurations.

Limitations

  • Terminology. “Few modern biologists use the term” (Judson, 2008). Turajlic et al. (2019) is a notable exception in the cancer field. Most researchers describe the same phenomena in mechanistic terms (chromothripsis, WGD, chromoplexy) without invoking Goldschmidt.
  • Retrospective identification. Whether a particular clone was a “hopeful monster” can only be determined retrospectively — by observing that it survived, expanded, and carried multiple large-scale genomic alterations acquired in a single event. There is no prospective criterion.
  • Frequency unknown. The article acknowledges that “much about hopeful monsters remains to be clinched” and the data are “suggestive rather than definitive.” The PCAWG data (22.3% chromothripsis) provides a lower bound for catastrophic genomic events but doesn’t tell us how many of those events produced adaptive clones (as opposed to passenger catastrophes).

Graph View

Backlinks